Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


DNAX Activating Protein of 12 kDa/Triggering Receptor Expressed on Myeloid Cells 2 Expression by Mouse and Human Liver Dendritic Cells: Functional Implications and Regulation of Liver Ischemia-Reperfusion Injury.

Nakao T, Ono Y, Dai H, Nakano R, Perez-Gutierrez A, Camirand G, Huang H, Geller DA, Thomson AW.

Hepatology. 2019 Aug;70(2):696-710. doi: 10.1002/hep.30334. Epub 2019 Feb 19.


Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance.

Ono Y, Perez-Gutierrez A, Nakao T, Dai H, Camirand G, Yoshida O, Yokota S, Stolz DB, Ross MA, Morelli AE, Geller DA, Thomson AW.

Hepatology. 2018 Apr;67(4):1499-1515. doi: 10.1002/hep.29529. Epub 2018 Feb 18.


Treg-Centric View of Immunosuppressive Drugs in Transplantation: A Balancing Act.

Camirand G, Riella LV.

Am J Transplant. 2017 Mar;17(3):601-610. doi: 10.1111/ajt.14029. Epub 2016 Oct 3. Review.


CD8+ Effector T Cell Migration to Pancreatic Islet Grafts Is Dependent on Cognate Antigen Presentation by Donor Graft Cells.

Zhang Q, Dai H, Yatim KM, Abou-Daya K, Williams AL, Oberbarnscheidt MH, Camirand G, Rudd CE, Lakkis FG.

J Immunol. 2016 Aug 15;197(4):1471-6. doi: 10.4049/jimmunol.1600832. Epub 2016 Jun 29.


New insights into the mechanisms of Treg function.

Rothstein DM, Camirand G.

Curr Opin Organ Transplant. 2015 Aug;20(4):376-84. doi: 10.1097/MOT.0000000000000212. Review.


CD45 ligation expands Tregs by promoting interactions with DCs.

Camirand G, Wang Y, Lu Y, Wan YY, Lin Y, Deng S, Guz G, Perkins DL, Finn PW, Farber DL, Flavell RA, Shlomchik WD, Lakkis FG, Rudd CE, Rothstein DM.

J Clin Invest. 2014 Oct;124(10):4603-13. doi: 10.1172/JCI74087. Epub 2014 Sep 9.


Cognate antigen directs CD8+ T cell migration to vascularized transplants.

Walch JM, Zeng Q, Li Q, Oberbarnscheidt MH, Hoffman RA, Williams AL, Rothstein DM, Shlomchik WD, Kim JV, Camirand G, Lakkis FG.

J Clin Invest. 2013 Jun;123(6):2663-71. doi: 10.1172/JCI66722. Epub 2013 May 15.


New perspectives in transplantation through intravital microscopy imaging.

Camirand G.

Curr Opin Organ Transplant. 2013 Feb;18(1):6-12. doi: 10.1097/MOT.0b013e32835c96c6. Review.


Multiphoton intravital microscopy of the transplanted mouse kidney.

Camirand G, Li Q, Demetris AJ, Watkins SC, Shlomchik WD, Rothstein DM, Lakkis FG.

Am J Transplant. 2011 Oct;11(10):2067-74. doi: 10.1111/j.1600-6143.2011.03671.x. Epub 2011 Aug 11.


Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.

Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H, Chalasani G, Sayegh MH, Najafian N, Rothstein DM.

J Clin Invest. 2011 Sep;121(9):3645-56. doi: 10.1172/JCI46274. Epub 2011 Aug 8.


Memory T cells migrate to and reject vascularized cardiac allografts independent of the chemokine receptor CXCR3.

Oberbarnscheidt MH, Walch JM, Li Q, Williams AL, Walters JT, Hoffman RA, Demetris AJ, Gerard C, Camirand G, Lakkis FG.

Transplantation. 2011 Apr 27;91(8):827-32. doi: 10.1097/TP.0b013e31820f0856.


Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice.

Wang Y, Camirand G, Lin Y, Froicu M, Deng S, Shlomchik WD, Lakkis FG, Rothstein DM.

J Immunol. 2011 Mar 1;186(5):2809-18. doi: 10.4049/jimmunol.0903805. Epub 2011 Jan 26.


Central tolerance to myogenic cell transplants does not include muscle neoantigens.

Camirand G, St├ęphan L, Rousseau J, Sackett MK, Caron NJ, Mills P, Kurtz J, Sykes M, Rothstein DM, Tremblay JP.

Transplantation. 2008 Jun 27;85(12):1791-801. doi: 10.1097/TP.0b013e31817726bc.


Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use.

Stephan L, Pichavant C, Bouchentouf M, Mills P, Camirand G, Tagmouti S, Rothstein D, Tremblay JP.

Cell Transplant. 2006;15(8-9):835-46.


Absence of innate MyD88 signaling promotes inducible allograft acceptance.

Walker WE, Nasr IW, Camirand G, Tesar BM, Booth CJ, Goldstein DR.

J Immunol. 2006 Oct 15;177(8):5307-16.


Antigen exposure during enhanced CTLA-4 expression promotes allograft tolerance in vivo.

Salvalaggio PR, Camirand G, Ariyan CE, Deng S, Rogozinski L, Basadonna GP, Rothstein DM.

J Immunol. 2006 Feb 15;176(4):2292-8.


Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerism.

Camirand G, Rousseau J, Ducharme ME, Rothstein DM, Tremblay JP.

Am J Transplant. 2004 Aug;4(8):1255-65. Erratum in: Am J Transplant. 2005 Dec;5(12):3024.


Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model.

Torrente Y, Camirand G, Pisati F, Belicchi M, Rossi B, Colombo F, El Fahime M, Caron NJ, Issekutz AC, Constantin G, Tremblay JP, Bresolin N.

J Cell Biol. 2003 Aug 4;162(3):511-20. Epub 2003 Jul 28.


Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation.

Camirand G, Caron NJ, Turgeon NA, Rossini AA, Tremblay JP.

Transplantation. 2002 Feb 15;73(3):453-61.


Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice.

Camirand G, Caron NJ, Asselin I, Tremblay JP.

Transplantation. 2001 Jul 15;72(1):38-44.


Intracellular delivery of a Tat-eGFP fusion protein into muscle cells.

Caron NJ, Torrente Y, Camirand G, Bujold M, Chapdelaine P, Leriche K, Bresolin N, Tremblay JP.

Mol Ther. 2001 Mar;3(3):310-8.

Supplemental Content

Loading ...
Support Center